PVCT
PROVECTUS BIOPHARMACEUTICALS, INC.
-0.00 (-6.91%)0.05USD48.0K成交股數21.5M市值–本益比(近四季)64.0股價營收比–營收年增(近四季)–下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0 · 0 |
| 近 180 天 淨額 | 0 |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2024-08-12 | 08-14 | Morris Jeffrey Allen | TenPercentOwner | C 轉換 | 264K | 2.86 | 756K | 4.3M | SEC |
| 2023-05-08 | 05-09 | Morris Jeffrey Allen | TenPercentOwner | C 轉換 | 189K | 2.86 | 540K | 4.0M | SEC |
| 2020-11-10 | 11-12 | Lacy John III | Director | A 獲配股票 | 100K | – | – | 200K | SEC |
| 2020-11-10 | 11-12 | Raines Heather | CFO | A 獲配股票 | 50.0K | – | – | 1.2M | SEC |
| 2020-11-10 | 11-12 | Horowitz Bruce | Chief Operating Officer | A 獲配股票 | 800K | – | – | 2.2M | SEC |
| 2019-03-25 | 03-27 | Raines Heather | Chief Financial Officer | A 獲配股票 | 50.0K | – | – | 1.2M | SEC |
| 2017-12-14 | 12-18 | Glass John R | See Remarks | P 公開市場買進 | 84.1K | 0.05 | 4K | 84.1K | SEC |
| 2017-12-14 | 12-18 | Glass John R | See Remarks | P 公開市場買進 | 116K | 0.05 | 6K | 200K | SEC |
| 2015-12-21 | 12-22 | WACHTER ERIC PHD | Chief Technology Officer | M 選擇權執行 | 120K | 1.02 | 122K | 5.5M | SEC |
| 2015-12-09 | 12-10 | CULPEPPER PETER R | CFO & COO | M 選擇權執行 | 139K | 0.94 | 131K | 1.3M | SEC |
| 2015-12-09 | 12-10 | CULPEPPER PETER R | CFO & COO | M 選擇權執行 | 6.4K | 0.94 | 6K | 191K | SEC |
| 2015-01-24 | 01-26 | WACHTER ERIC PHD | Chief Technology Officer | M 選擇權執行 | 185K | 1.02 | 189K | 824K | SEC |
| 2015-01-07 | 01-07 | SCOTT TIMOTHY PHD | President | M 選擇權執行 | 76.8K | 0.64 | 49K | 503K | SEC |
| 2015-01-07 | 01-07 | CULPEPPER PETER R | CFO & COO | M 選擇權執行 | 33.3K | 0.75 | 25K | 154K | SEC |
| 2015-01-07 | 01-07 | CULPEPPER PETER R | CFO & COO | M 選擇權執行 | 29.8K | 0.94 | 28K | 184K | SEC |
| 2014-12-30 | 12-30 | SCOTT TIMOTHY PHD | President | M 選擇權執行 | 126K | 0.64 | 81K | 426K | SEC |
| 2014-10-29 | 10-31 | SCOTT TIMOTHY PHD | President | M 選擇權執行 | 96.9K | 0.64 | 62K | 1.5M | SEC |
| 2014-06-28 | 07-01 | CULPEPPER PETER R | CFO & COO | M 選擇權執行 | 100K | 1.25 | 125K | 1.1M | SEC |
| 2014-05-19 | 05-20 | SCOTT TIMOTHY PHD | President | M 選擇權執行 | 25.0K | 0.95 | 24K | 1.4M | SEC |
| 2014-05-19 | 05-20 | SCOTT TIMOTHY PHD | President | M 選擇權執行 | 25.0K | 0.95 | 24K | 1.4M | SEC |
| 2014-03-20 | 03-24 | WACHTER ERIC PHD | Chief Technology Officer | M 選擇權執行 | 25.0K | 0.95 | 24K | 5.4M | SEC |
| 2014-03-20 | 03-24 | WACHTER ERIC PHD | Chief Technology Officer | M 選擇權執行 | 14.2K | 0.75 | 11K | 5.4M | SEC |
| 2014-03-20 | 03-24 | WACHTER ERIC PHD | Chief Technology Officer | M 選擇權執行 | 600K | 0.93 | 558K | 6.0M | SEC |
| 2014-02-26 | 02-28 | SCOTT TIMOTHY PHD | President | M 選擇權執行 | 300K | 1.10 | 330K | 300K | SEC |
| 2014-02-26 | 02-28 | CULPEPPER PETER R | CFO & COO | M 選擇權執行 | 68.6K | 1.10 | 75K | 1.0M | SEC |
| 2014-02-26 | 02-28 | CULPEPPER PETER R | CFO & COO | M 選擇權執行 | 121K | 1.10 | 133K | 121K | SEC |
| 2013-09-20 | 09-24 | Koe Jan | Director | P 公開市場買進 | 100K | – | – | 586K | SEC |
| 2013-05-29 | 05-30 | DEES H CRAIG | Chief Executive Officer | M 選擇權執行 | 18.8K | 0.32 | 6K | 1.5M | SEC |
| 2013-05-29 | 05-30 | DEES H CRAIG | Chief Executive Officer | M 選擇權執行 | 25.0K | 0.60 | 15K | 1.5M | SEC |
| 2012-12-03 | 12-03 | CULPEPPER PETER R | CFO, COO | P 公開市場買進 | 133K | – | – | 944K | SEC |
| 2012-11-16 | 11-20 | CULPEPPER PETER R | CFO, COO | P 公開市場買進 | 133K | – | – | 810K | SEC |
| 2012-11-16 | 11-20 | WACHTER ERIC PHD | Chief Technology Officer | P 公開市場買進 | 667K | – | – | 5.4M | SEC |
| 2011-12-05 | 12-07 | WACHTER ERIC PHD | Vice President Pharmaceuticals | M 選擇權執行 | 100K | 0.75 | 75K | 4.7M | SEC |
| 2011-12-01 | 12-02 | WACHTER ERIC PHD | Vice President Pharmaceuticals | M 選擇權執行 | 100K | 0.93 | 93K | 4.6M | SEC |
| 2011-11-23 | 11-28 | WACHTER ERIC PHD | Vice President Pharmaceuticals | M 選擇權執行 | 100K | 0.93 | 93K | 4.5M | SEC |
| 2011-10-19 | 10-20 | WACHTER ERIC PHD | Vice President Pharmaceuticals | M 選擇權執行 | 100K | 0.93 | 93K | 4.4M | SEC |
| 2011-10-06 | 10-06 | SCOTT TIMOTHY PHD | President | M 選擇權執行 | 25.0K | 0.60 | 15K | 1.4M | SEC |
| 2011-10-06 | 10-06 | SCOTT TIMOTHY PHD | President | M 選擇權執行 | 75.0K | 0.32 | 24K | 1.4M | SEC |
| 2011-09-07 | 09-08 | WACHTER ERIC PHD | Vice President Pharmaceuticals | M 選擇權執行 | 100K | 0.93 | 93K | 4.3M | SEC |
| 2011-07-29 | 08-01 | WACHTER ERIC PHD | Vice President Pharmaceuticals | M 選擇權執行 | 100K | 1.00 | 100K | 4.2M | SEC |
| 2011-05-03 | 05-04 | CULPEPPER PETER R | Chief Financial Officer | M 選擇權執行 | 133K | 0.75 | 100K | 677K | SEC |
| 2011-05-03 | 05-04 | WACHTER ERIC PHD | Vice President Pharmaceuticals | M 選擇權執行 | 100K | 1.00 | 100K | 4.1M | SEC |
| 2011-04-20 | 04-21 | WACHTER ERIC PHD | Vice President Pharmaceuticals | M 選擇權執行 | 100K | 1.00 | 100K | 4.0M | SEC |
| 2011-04-12 | 04-13 | WACHTER ERIC PHD | Vice President Pharmaceuticals | M 選擇權執行 | 150K | 1.00 | 150K | 3.9M | SEC |
| 2011-02-07 | 02-08 | WACHTER ERIC PHD | Vice President Pharmaceuticals | M 選擇權執行 | 8.3K | 0.75 | 6K | 3.8M | SEC |
| 2011-02-03 | 02-04 | WACHTER ERIC PHD | Vice President Pharmaceuticals | M 選擇權執行 | 125K | 0.75 | 94K | 3.8M | SEC |
| 2010-12-29 | 12-30 | CULPEPPER PETER R | Chief Financial Officer | M 選擇權執行 | 133K | 0.75 | 100K | 544K | SEC |
| 2010-12-29 | 12-30 | WACHTER ERIC PHD | Vice President Pharmaceuticals | M 選擇權執行 | 400K | 1.00 | 400K | 3.6M | SEC |
| 2010-11-19 | 11-22 | WACHTER ERIC PHD | Vice President Pharmaceuticals | M 選擇權執行 | 100K | 1.00 | 100K | 3.2M | SEC |
| 2010-09-07 | 09-07 | WACHTER ERIC PHD | Vice President Pharmaceuticals | M 選擇權執行 | 100K | 1.00 | 100K | 3.1M | SEC |
| 2010-07-09 | 07-12 | WACHTER ERIC PHD | Vice President Pharmaceuticals | M 選擇權執行 | 75.0K | 1.10 | 83K | 3.0M | SEC |
| 2010-04-28 | 04-29 | WACHTER ERIC PHD | Vice President Pharmaceuticals | M 選擇權執行 | 105K | 0.64 | 68K | 2.9M | SEC |
| 2010-04-28 | 04-29 | WACHTER ERIC PHD | Vice President Pharmaceuticals | M 選擇權執行 | 52.4K | 0.75 | 39K | 3.0M | SEC |
| 2009-12-22 | 12-23 | WACHTER ERIC PHD | Vice President Pharmaceuticals | M 選擇權執行 | 83.3K | 0.94 | 78K | 2.8M | SEC |
| 2009-12-22 | 12-23 | WACHTER ERIC PHD | Vice President Pharmaceuticals | M 選擇權執行 | 15.0K | 1.02 | 15K | 2.8M | SEC |
| 2009-08-26 | 08-27 | WACHTER ERIC PHD | Vice President Pharmaceuticals | M 選擇權執行 | 50.0K | 0.94 | 47K | 2.7M | SEC |
| 2009-07-17 | 07-20 | WACHTER ERIC PHD | Vice President Pharmaceuticals | M 選擇權執行 | 20.0K | 1.02 | 20K | 2.7M | SEC |
| 2009-07-08 | 07-08 | FUCHS STUART | Director | A 獲配股票 | 70.0K | – | – | 871K | SEC |
| 2009-06-11 | 06-11 | CULPEPPER PETER R | Chief Financial Officer | M 選擇權執行 | 150K | 0.64 | 96K | 410K | SEC |
| 2009-06-08 | 06-09 | WACHTER ERIC PHD | Vice President Pharmaceuticals | M 選擇權執行 | 109K | 0.64 | 70K | 2.6M | SEC |
| 2009-04-01 | 04-02 | WACHTER ERIC PHD | Vice President Pharmaceuticals | M 選擇權執行 | 46.9K | 0.64 | 30K | 2.5M | SEC |
| 2008-11-20 | 11-24 | WACHTER ERIC PHD | Vice President Pharmaceuticals | M 選擇權執行 | 66.7K | 0.94 | 63K | 2.5M | SEC |
| 2008-06-24 | 06-25 | WACHTER ERIC PHD | Executive VP Pharmaceuticals | M 選擇權執行 | 30.0K | 1.02 | 31K | 2.4M | SEC |
| 2008-06-12 | 06-17 | CULPEPPER PETER R | Chief Financial Officer | M 選擇權執行 | 44.8K | 1.10 | 49K | 260K | SEC |
| 2008-06-12 | 06-16 | CULPEPPER PETER R | Chief Financial Officer | M 選擇權執行 | 44.8K | 1.10 | 49K | 110K | SEC |
| 2008-05-30 | 05-30 | WACHTER ERIC PHD | Executive VP Pharmaceuticals | M 選擇權執行 | 25.0K | 0.62 | 16K | 2.4M | SEC |
| 2008-05-30 | 05-30 | WACHTER ERIC PHD | Executive VP Pharmaceuticals | M 選擇權執行 | 38.3K | 0.64 | 24K | 2.4M | SEC |
| 2008-04-09 | 04-10 | WACHTER ERIC PHD | Vice President Pharmaceuticals | M 選擇權執行 | 75.0K | 0.32 | 24K | 2.3M | SEC |
| 2008-04-09 | 04-10 | WACHTER ERIC PHD | Vice President Pharmaceuticals | M 選擇權執行 | 25.0K | 0.60 | 15K | 2.3M | SEC |
| 2007-12-27 | 12-27 | WACHTER ERIC PHD | Vice President Pharmaceuticals | M 選擇權執行 | 331K | 0.94 | 311K | 2.2M | SEC |
| 2007-11-14 | 11-14 | DEES H CRAIG | Chief Executive Officer | M 選擇權執行 | 6.3K | 0.32 | 2K | 1.5M | SEC |
| 2007-11-12 | 11-13 | CULPEPPER PETER R | Chief Financial Officer | M 選擇權執行 | 50.0K | 0.64 | 32K | 216K | SEC |
| 2007-09-22 | 09-24 | ADAMS DONALD E | TenPercentOwner | S 公開市場賣出 | 5.0K | 2.98 | 15K | 5.5M | SEC |
| 2007-09-13 | 09-13 | DEES H CRAIG | Chief Executive Officer | M 選擇權執行 | 9.4K | 0.32 | 3K | 1.4M | SEC |
| 2007-09-13 | 09-13 | CULPEPPER PETER R | Chief Financial Officer | M 選擇權執行 | 25.0K | 0.64 | 16K | 166K | SEC |
| 2007-09-06 | 09-24 | ADAMS DONALD E | TenPercentOwner | S 公開市場賣出 | 5.0K | 2.90 | 15K | 5.5M | SEC |
| 2007-09-06 | 09-24 | ADAMS DONALD E | TenPercentOwner | S 公開市場賣出 | 50.0K | 2.80 | 140K | 5.6M | SEC |
| 2007-09-06 | 09-24 | ADAMS DONALD E | TenPercentOwner | S 公開市場賣出 | 5.0K | 2.86 | 14K | 5.5M | SEC |
| 2007-09-06 | 09-24 | ADAMS DONALD E | TenPercentOwner | S 公開市場賣出 | 5.0K | 2.99 | 15K | 5.5M | SEC |
| 2007-09-06 | 09-24 | ADAMS DONALD E | TenPercentOwner | S 公開市場賣出 | 5.0K | 2.89 | 14K | 5.5M | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 ·
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| 沒有 13F 資料。 | ||||
持有機構數近 12 季
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 802K |
|---|---|
| 與上期比 | 0.0% |
| 佔流通股數 | 0.19% |
| 日均成交量 | 358K |
| 回補天數 | 2.2 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 802K | 0.0% | 0.19% | 358K | 2.2 |
| 2026-08-14 | 802K | +0.0% | 0.19% | 209K | 3.8 |
| 2026-07-31 | 802K | -0.1% | 0.19% | 382K | 2.1 |
| 2026-07-15 | 803K | +10237.3% | 0.19% | 545K | 1.5 |
| 2026-06-30 | 7.8K | -99.0% | 0.00% | 286K | 1.0 |
| 2026-06-15 | 803K | +41110.7% | 0.19% | 183K | 4.4 |
| 2026-05-29 | 1.9K | -89.5% | 0.00% | 325K | 1.0 |
| 2026-05-15 | 18.5K | -97.7% | 0.00% | 318K | 1.0 |
| 2026-04-30 | 803K | -0.8% | 0.19% | 417K | 1.9 |
| 2026-04-15 | 809K | -5.3% | 0.19% | 383K | 2.1 |
| 2026-03-31 | 855K | +4.7% | 0.20% | 895K | 1.0 |
| 2026-03-13 | 817K | +1.6% | 0.19% | 394K | 2.1 |
| 2026-02-27 | 804K | +0.4% | 0.19% | 759K | 1.1 |
| 2026-02-13 | 801K | -0.1% | 0.19% | 1.1M | 1.0 |
| 2026-01-30 | 802K | +0.1% | 0.19% | 733K | 1.1 |
| 2026-01-15 | 801K | 0.0% | 0.19% | 264K | 3.0 |
| 2025-12-31 | 801K | +16004.0% | 0.19% | 643K | 1.3 |
| 2025-12-15 | 5.0K | +895.0% | 0.00% | 420K | 1.0 |
| 2025-11-28 | 500 | 0.0% | 0.00% | 641K | 1.0 |
| 2025-11-14 | 500 | -0.4% | 0.00% | 667K | 1.0 |
| 2025-10-31 | 502 | +0.2% | 0.00% | 331K | 1.0 |
| 2025-10-15 | 501 | -99.9% | 0.00% | 386K | 1.0 |
| 2025-09-30 | 628K | +29.3% | 0.15% | 483K | 1.3 |
| 2025-09-15 | 485K | +8.4% | 0.12% | 524K | 1.0 |
| 2025-08-29 | 448K | +1781.0% | 0.11% | 255K | 1.8 |
| 2025-08-15 | 23.8K | -47.4% | 0.01% | 242K | 1.0 |